Bioceres and Union Acquisition Corp.’s Transfer of Listing to NYSE American

Marval, O’Farrell & Mairal, Linklaters, Mitrani, Caballero & Ruiz Moreno and Arnold & Porter Kaye Scholer advised on the transaction

Union Acquisition Corp. (NYSE: LTN, “UAC”) and Bioceres, Inc. executed the transfer of the listing of its ordinary shares and warrants to the NYSE American LLC (“NYSE American”) from the New York Stock Exchange (“NYSE”) following completion of its business combination.

Upon completion of the business combination, UAC will change its name to Bioceres Crop Solutions Corp. The ordinary shares and warrants of Bioceres Crop Solutions Corp. will trade under the proposed symbols “BIOX” and “BIOX WS,” respectively.

Union Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. UAC’s efforts to identify a prospective target business are not limited to any particular industry or geographic region, although the Company has focused on target businesses located in Latin America. The Company is led by Juan Sartori, Chairman of the Board of the Company and Chairman and founder of Union Group International Ltd., and Kyle P. Bransfield, Chief Executive Officer of the Company and Partner of Atlantic-Pacific Capital, Inc.

Bioceres is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. Unlike most industry participants that specialize in a single technology, chemistry, product, condition or stage of plant development, Bioceres has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Bioceres’ platform is designed to cost effectively bring high value technologies to market through an open architecture approach. Bioceres’ headquarters and primary operations are based in Argentina, which is its key end-market as well as one of the largest markets globally for GM crops. Through its main operational subsidiary, Rizobacter, the Company has a growing and significant international presence, particularly in Brazil and Paraguay. Bioceres leverages its relationship with its historical shareholders, many of whom are agricultural leaders and key participants in Bioceres’ end markets, to increase adoption of its products and technologies.

Marval, O’Farrell & Mairal advised Bioceres Argentina SA with Hernán Slemenson (Picture), Fernando Hernández and Diego Krischcautzky.

Linklaters advised Bioceres in US.

Mitrani, Caballero & Ruiz Moreno advised Union Acquisition Corp. with Diego Parise and Cristian Kruger.

Arnold & Porter Kaye Scholer LLP y Graubard Miller advised Union Acquisition Corp. in US.

Involved fees earner: Fernando Hernández – Marval, O’Farrell & Mairal; Diego Krischcautzky – Marval, O’Farrell & Mairal; Hernán Slemenson – Marval, O’Farrell & Mairal; Cristian Kruger – Mitrani Caballero & Ruiz Moreno; Diego Parise – Mitrani Caballero & Ruiz Moreno;

Law Firms: Marval, O’Farrell & Mairal; Mitrani Caballero & Ruiz Moreno;

Clients: Bioceres S.A.; Union Acquisition Corp.;

Print Friendly, PDF & Email

Author: Ambrogio Visconti.